Report

Injection safety in the context of coronavirus disease (COVID-19) vaccination

This document serves to update the policy brief Injection safety in the context of coronavirus disease (COVID-19) vaccination (IS Policy Brief), with additional guidance. The IS Policy Brief remains valid and highlights the overall importance of reinforcing injection safety in the context of the pandemic, especially considering the significant resulting increase in the number of injections being administered worldwide.

This Addendum confirms that substituting syringes with re-use prevention features (RUP) for auto-disable (AD) syringes may exceptionally be necessary to address shortages of 0.3 ml AD syringes. In addition to the shortages of this specialty size, this Addendum to the IS Policy Brief further acknowledges compounding factors that will exacerbate availability challenges of AD syringes for some COVID-19 vaccines. In particular, some dosing regimens now call for non-standard dose volumes that do not correspond to any existing size of AD syringes.

Languages

  • English

Publication year

2022

Type

Report

Categories

  • Service delivery

Diseases

  • COVID-19

Topic references

COVAX-PFIZER

TitleAuthorYearTypeLanguage
Capacitación sobre la manipulación, el almacenamiento y el transporte de la vacuna Pfizer-BioNTech contra la COVID-19 ARNm COMIRNATY® (Tozinameran)World Health Organization (WHO), UNICEF2021TrainingSpanish
COVID-19 Vaccine Rollout Technical brief delivery strategies optionsCOVAX Partners2021PresentationEnglish
Formação sobre manuseamento, armazenamento e transporte da Vacina mRNA contra a COVID-19 Pfizer-BioNTech COMIRNATY® (Tozinameran)World Health Organization (WHO), UNICEF2021TrainingPortuguese
Formation sur la manipulation, le stockage et le transport du vaccin Pfizer BioNTech COVID-19OMS - Organisation Mondiale de la Santé, UNICEF2021TrainingFrench
Injection safety in the context of coronavirus disease (COVID-19) vaccinationWorld Health Organization (WHO)2022ReportEnglish
Options de stratégies d'administration du vaccin COVID-19COVAX Partners2021PresentationFrench
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)World Health Organization (WHO), UNICEF2021TrainingEnglish
Training on Pfizer‒BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran) - Updated 5 October 2021Gavi, the Vaccine Alliance, UNICEF, World Health Organization (WHO)2021TrainingEnglish
Обучающий курс по хранению, транспортировке и обращению с мРНК-вакциной от COVID-19 COMIRNATY® (Tozinameran) производства компании Pfizer BioNTechWorld Health Organization (WHO), UNICEF2021TrainingRussian
دورة تدريبية بشأن التعامل مع لقاح فايزر-بيونتيك المضاد لكوفيد-19 وطريقة تخزينه ونقلهCOVAX Partners2021TrainingArabic